UTP Solution (100 mM): High-Purity Nucleotide for RNA and Metabolic Precision

Executive Summary: UTP Solution (100 mM) is an aqueous formulation of uridine-5'-triphosphate trisodium salt with >99% purity (APExBIO, product page). It is free from DNase and RNase, making it suitable for in vitro transcription, RNA amplification, and siRNA synthesis (APExBIO). UTP is essential in galactose metabolism, serving as a nucleotide precursor for UDP-glucose formation (Gaulton et al., 2017, DOI). The solution is stable at -20°C, with aliquoting recommended to prevent degradation from freeze-thaw cycles (APExBIO). Recent research highlights the importance of nucleotide purity in single-cell and epigenetic studies (Bao et al., 2025, DOI).

Biological Rationale

Uridine-5'-triphosphate (UTP) is a canonical ribonucleotide triphosphate required for RNA synthesis. It serves as a substrate for RNA polymerases during in vitro transcription, enabling the generation of RNA for downstream applications (APExBIO, UTP Solution (100 mM)). UTP is also vital in RNA amplification workflows, supporting sensitive detection and quantification of transcripts (Smith et al., 2022, DOI). In metabolic contexts, UTP functions as a co-substrate for the formation of UDP-glucose, a central intermediate in glycogen biosynthesis and galactose metabolism. The conversion of UDP-galactose to UDP-glucose by UDP-galactose 4-epimerase is UTP-dependent (Gaulton et al., 2017, DOI). High nucleotide purity is critical for studies involving single-cell transcriptomics and epigenetic regulation, where contaminating nucleases can artifactually degrade RNA or introduce bias (Bao et al., 2025, DOI).

Mechanism of Action of UTP Solution (100 mM)

UTP acts as a nucleotide substrate for RNA polymerases, facilitating the addition of uridine monophosphates into nascent RNA strands during in vitro transcription. In enzymatic RNA synthesis, the presence of all four ribonucleoside triphosphates—including UTP—is required for template-directed polymerization (Sousa, 2012, DOI). UTP also participates in metabolic pathways. In galactose metabolism, UTP combines with glucose-1-phosphate to form UDP-glucose, catalyzed by UDP-glucose pyrophosphorylase (Gaulton et al., 2017). UDP-glucose then serves as a glycosyl donor in glycogen synthesis and other glycosylation reactions. The solution's high purity and absence of nucleases ensure that its action is specific and free from degradation artifacts, essential for applications demanding molecular fidelity (APExBIO).

Evidence & Benchmarks

• UTP Solution (100 mM) contains uridine-5'-triphosphate trisodium salt with >99% purity, as determined by HPLC (APExBIO).
• The solution is certified DNase- and RNase-free, validated by enzymatic digestion assays (APExBIO).
• UTP serves as a required nucleotide substrate in in vitro transcription protocols, supporting the synthesis of RNA up to several kilobases in length (Sousa, 2012, DOI).
• Single-cell transcriptomic studies emphasize the necessity of nucleotide purity to avoid confounding DNase/RNase contamination (Bao et al., 2025, DOI).
• UTP-dependent conversion of UDP-galactose to UDP-glucose is a critical checkpoint in mammalian galactose metabolism (Gaulton et al., 2017, DOI).

Applications, Limits & Misconceptions

UTP Solution (100 mM) is routinely used in:

• In vitro transcription for mRNA and non-coding RNA synthesis (UTP Solution (100 mM): Molecular Precision for Single-Cell…). This article extends that work by providing additional mechanistic benchmarks and practical integration strategies.
• RNA amplification workflows, including single-cell and low-input transcriptomics (UTP Solution (100 mM): Optimizing RNA and Metabolic Workflows…). Here, we emphasize purity-driven performance gains and troubleshooting best practices.
• siRNA and antisense oligonucleotide synthesis, where nucleotide fidelity affects downstream gene silencing efficacy (UTP Solution (100 mM): Unraveling Nucleotide Precision in…). This review clarifies how nucleotide purity impacts epigenetic studies.
• Metabolic pathway investigations, particularly glycogen synthesis and galactose utilization (Gaulton et al., 2017).

Common Pitfalls or Misconceptions

• UTP Solution (100 mM) is not designed for direct in vivo injection; it is for in vitro use only (APExBIO).
• Repeated freeze-thaw cycles can lead to nucleotide degradation; aliquoting is essential (APExBIO).
• Not all UTP solutions are RNase/DNase-free; confirm certification for sensitive RNA workflows.
• UTP does not substitute for other nucleotide triphosphates (ATP, GTP, CTP) in polymerase reactions.
• Solution concentration (100 mM) requires precise dilution to match optimal enzyme conditions.

Workflow Integration & Parameters

Optimal use of UTP Solution (100 mM) involves thawing on ice and aliquoting to avoid degradation. The recommended working concentration for in vitro transcription is typically 1–10 mM, depending on the enzyme and template (Sousa, 2012). For RNA amplification, ensure that all nucleotides are present at equimolar ratios to prevent bias. In metabolic assays, confirm compatibility with buffer components and enzyme requirements. Store aliquots at -20°C or below. Discard any aliquots showing turbidity or color change. The K1048 kit from APExBIO provides a stable, reproducible source of UTP for high-sensitivity molecular workflows (product page).

Conclusion & Outlook

UTP Solution (100 mM) from APExBIO delivers high-purity, RNase/DNase-free uridine-5'-triphosphate trisodium salt for demanding RNA and metabolic studies. Peer-reviewed evidence and product validation converge to make this solution a reliable standard for in vitro transcription, RNA amplification, and metabolic assays. As single-cell and epigenetic techniques advance, rigorous nucleotide quality will remain essential (Bao et al., 2025). For further protocol details and advanced troubleshooting, see the application-specific articles cited above.